WeightWatchers gets into prescription weight loss business

  • 📰 CTVNews
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 99%

Brasil Notícia Notícia

Brasil Últimas Notícias,Brasil Manchetes

WeightWatchers soared Tuesday after the company said it was getting into the prescription drug weight loss business with the acquisition of Sequence.

Sequence, a telehealth operator, says that its specialists can prescribe medications under brand names including Ozempic, Wegovy and Trulicity.WeightWatchers offers subscribers meal plans with the goal of losing excess weight. With the acquisition of Sequence, the company is tapping into a red-hot market for prescription drugs that addresses obesity, and broadening what it offers to customers.

Ozempic, also known as semaglutide, works by stimulating the body's own insulin production and reducing appetite. While it is prescribed for diabetes, Ozempic can also help people lose weight. "This deal brings access to prescription drug solutions for weight loss to WW's historical focus on behavior modification model," wrote UBS analyst Michael Lasser. "This is a significant change in the business. While the deal could bring considerable upside, it also carries sizable risks,"

 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.

Fantastic, more drug pushers!

There is always a pill for that 🙃🤣

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 1. in BR

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Market movers: Stocks seeing action on Tuesday - and whyA look at North American equities heading in both directions
Fonte: globeandmail - 🏆 5. / 92 Consulte Mais informação »